| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | costamere | 1.79e-04 | 22 | 19 | 2 | GO:0043034 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.32e-04 | 25 | 19 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 1.09e-03 | 54 | 19 | 2 | GO:0030286 | |
| HumanPheno | Abnormal lung development | 1.09e-04 | 244 | 3 | 3 | HP:4000059 | |
| HumanPheno | Abnormal nasopharynx morphology | 1.15e-04 | 249 | 3 | 3 | HP:0001739 | |
| HumanPheno | Abnormal pharynx morphology | 1.32e-04 | 260 | 3 | 3 | HP:0033151 | |
| HumanPheno | Recurrent lower respiratory tract infections | 1.79e-04 | 288 | 3 | 3 | HP:0002783 | |
| HumanPheno | Abnormality of the pharynx | 2.46e-04 | 320 | 3 | 3 | HP:0000600 | |
| HumanPheno | Peribronchovascular interstitial thickening | 2.70e-04 | 49 | 3 | 2 | HP:0025177 | |
| HumanPheno | Pulmonary situs ambiguus | 2.70e-04 | 49 | 3 | 2 | HP:0011617 | |
| HumanPheno | Abnormal pulmonary situs morphology | 2.70e-04 | 49 | 3 | 2 | HP:0011615 | |
| HumanPheno | Lithoptysis | 2.70e-04 | 49 | 3 | 2 | HP:0032543 | |
| HumanPheno | Ectopic pregnancy | 2.70e-04 | 49 | 3 | 2 | HP:0031456 | |
| HumanPheno | Atrial situs ambiguous | 2.82e-04 | 50 | 3 | 2 | HP:0011539 | |
| HumanPheno | Abnormal inferior vena cava morphology | 3.17e-04 | 53 | 3 | 2 | HP:0025576 | |
| HumanPheno | Abnormal atrial arrangement | 3.29e-04 | 54 | 3 | 2 | HP:0011535 | |
| HumanPheno | Nasal congestion | 4.06e-04 | 60 | 3 | 2 | HP:0001742 | |
| HumanPheno | Recurrent mycobacterial infections | 4.34e-04 | 62 | 3 | 2 | HP:0011274 | |
| HumanPheno | Abnormal middle ear morphology | 4.46e-04 | 390 | 3 | 3 | HP:0008609 | |
| HumanPheno | Wheezing | 4.62e-04 | 64 | 3 | 2 | HP:0030828 | |
| HumanPheno | Polysplenia | 4.92e-04 | 66 | 3 | 2 | HP:0001748 | |
| HumanPheno | Recurrent sinopulmonary infections | 5.22e-04 | 68 | 3 | 2 | HP:0005425 | |
| HumanPheno | Productive cough | 5.22e-04 | 68 | 3 | 2 | HP:0031245 | |
| HumanPheno | Recurrent upper and lower respiratory tract infections | 5.22e-04 | 68 | 3 | 2 | HP:0002873 | |
| HumanPheno | Chronic sinusitis | 5.38e-04 | 69 | 3 | 2 | HP:0011109 | |
| HumanPheno | Chronic rhinitis | 6.02e-04 | 73 | 3 | 2 | HP:0002257 | |
| HumanPheno | Nasal polyposis | 6.19e-04 | 74 | 3 | 2 | HP:0100582 | |
| HumanPheno | Atelectasis | 7.23e-04 | 80 | 3 | 2 | HP:0100750 | |
| HumanPheno | Abnormal nasal mucosa morphology | 7.23e-04 | 80 | 3 | 2 | HP:0000433 | |
| HumanPheno | Persistent left superior vena cava | 7.79e-04 | 83 | 3 | 2 | HP:0005301 | |
| HumanPheno | Anomalous pulmonary venous return | 7.79e-04 | 83 | 3 | 2 | HP:0010772 | |
| HumanPheno | Female infertility | 7.98e-04 | 84 | 3 | 2 | HP:0008222 | |
| HumanPheno | Abnormal superior vena cava morphology | 8.17e-04 | 85 | 3 | 2 | HP:0025575 | |
| HumanPheno | Transposition of the great arteries | 8.17e-04 | 85 | 3 | 2 | HP:0001669 | |
| HumanPheno | Abnormal vena cava morphology | 8.75e-04 | 88 | 3 | 2 | HP:0030971 | |
| HumanPheno | Abnormal vena cava morphology | 8.95e-04 | 89 | 3 | 2 | HP:0005345 | |
| HumanPheno | Abnormal pulmonary vein morphology | 8.95e-04 | 89 | 3 | 2 | HP:0030968 | |
| HumanPheno | Abnormality of the pulmonary veins | 8.95e-04 | 89 | 3 | 2 | HP:0011718 | |
| HumanPheno | Asplenia | 9.36e-04 | 91 | 3 | 2 | HP:0001746 | |
| HumanPheno | Double outlet right ventricle | 9.99e-04 | 94 | 3 | 2 | HP:0001719 | |
| HumanPheno | Congenital malformation of the right heart | 1.04e-03 | 96 | 3 | 2 | HP:0011723 | |
| HumanPheno | Aplasia/Hypoplasia of the spleen | 1.09e-03 | 98 | 3 | 2 | HP:0010451 | |
| HumanPheno | Supernumerary spleens | 1.15e-03 | 101 | 3 | 2 | HP:0009799 | |
| HumanPheno | Decreased fertility in females | 1.22e-03 | 104 | 3 | 2 | HP:0000868 | |
| HumanPheno | Rhinitis | 1.44e-03 | 113 | 3 | 2 | HP:0012384 | |
| HumanPheno | Abnormal sperm physiology | 1.49e-03 | 115 | 3 | 2 | HP:0034809 | |
| HumanPheno | Abnormal sperm motility | 1.49e-03 | 115 | 3 | 2 | HP:0012206 | |
| HumanPheno | Abnormal spleen morphology | 1.74e-03 | 613 | 3 | 3 | HP:0025408 | |
| HumanPheno | Abnormal cardiac atrium morphology | 1.77e-03 | 617 | 3 | 3 | HP:0005120 | |
| HumanPheno | Abnormality of the spleen | 1.98e-03 | 640 | 3 | 3 | HP:0001743 | |
| HumanPheno | Abnormal breath sound | 2.00e-03 | 133 | 3 | 2 | HP:0030829 | |
| HumanPheno | Abnormal sputum | 2.09e-03 | 136 | 3 | 2 | HP:0032016 | |
| HumanPheno | Airway obstruction | 2.12e-03 | 137 | 3 | 2 | HP:0006536 | |
| HumanPheno | Recurrent respiratory infections | 2.17e-03 | 660 | 3 | 3 | HP:0002205 | |
| HumanPheno | Abdominal situs inversus | 2.27e-03 | 142 | 3 | 2 | HP:0003363 | |
| HumanPheno | Abnormal spatial orientation of the cardiac segments | 2.27e-03 | 142 | 3 | 2 | HP:0011534 | |
| HumanPheno | Abnormality of abdominal situs | 2.27e-03 | 142 | 3 | 2 | HP:0011620 | |
| HumanPheno | Situs inversus totalis | 2.27e-03 | 142 | 3 | 2 | HP:0001696 | |
| HumanPheno | Heterotaxy | 2.37e-03 | 145 | 3 | 2 | HP:0030853 | |
| HumanPheno | Clubbing | 2.60e-03 | 152 | 3 | 2 | HP:0001217 | |
| HumanPheno | Neonatal respiratory distress | 2.67e-03 | 154 | 3 | 2 | HP:0002643 | |
| HumanPheno | Chronic otitis media | 2.74e-03 | 156 | 3 | 2 | HP:0000389 | |
| HumanPheno | Abnormal pulmonary thoracic imaging finding | 2.77e-03 | 157 | 3 | 2 | HP:0031983 | |
| HumanPheno | Intestinal malrotation | 2.77e-03 | 157 | 3 | 2 | HP:0002566 | |
| HumanPheno | Dextrocardia | 2.85e-03 | 159 | 3 | 2 | HP:0001651 | |
| HumanPheno | Abnormal anatomic location of the heart | 2.88e-03 | 160 | 3 | 2 | HP:0004307 | |
| HumanPheno | Cough | 2.88e-03 | 160 | 3 | 2 | HP:0012735 | |
| HumanPheno | Abnormal pulmonary interstitial morphology | 2.92e-03 | 161 | 3 | 2 | HP:0006530 | |
| HumanPheno | Sinusitis | 3.25e-03 | 170 | 3 | 2 | HP:0000246 | |
| HumanPheno | Bronchiectasis | 3.44e-03 | 175 | 3 | 2 | HP:0002110 | |
| HumanPheno | Ventriculomegaly | 3.72e-03 | 790 | 3 | 3 | HP:0002119 | |
| HumanPheno | Pregnancy history | 3.72e-03 | 182 | 3 | 2 | HP:0002686 | |
| HumanPheno | Past medical history | 3.76e-03 | 183 | 3 | 2 | HP:0032443 | |
| HumanPheno | Abnormality of the lymphatic system | 3.76e-03 | 793 | 3 | 3 | HP:0100763 | |
| HumanPheno | Respiratory tract infection | 3.82e-03 | 797 | 3 | 3 | HP:0011947 | |
| HumanPheno | Abnormal paranasal sinus morphology | 4.01e-03 | 189 | 3 | 2 | HP:0000245 | |
| HumanPheno | Abnormal fingertip morphology | 4.62e-03 | 203 | 3 | 2 | HP:0001211 | |
| HumanPheno | Male infertility | 4.89e-03 | 209 | 3 | 2 | HP:0003251 | |
| HumanPheno | Abnormal bronchus morphology | 5.17e-03 | 215 | 3 | 2 | HP:0025426 | |
| HumanPheno | Recurrent bacterial infections | 5.66e-03 | 225 | 3 | 2 | HP:0002718 | |
| HumanPheno | Recurrent otitis media | 5.76e-03 | 227 | 3 | 2 | HP:0000403 | |
| HumanPheno | Decreased fertility in males | 6.22e-03 | 236 | 3 | 2 | HP:0012041 | |
| HumanPheno | Recurrent upper respiratory tract infections | 6.27e-03 | 237 | 3 | 2 | HP:0002788 | |
| HumanPheno | Rod-cone dystrophy | 6.37e-03 | 239 | 3 | 2 | HP:0000510 | |
| Domain | PDZ | 3.74e-04 | 141 | 19 | 3 | PF00595 | |
| Domain | PDZ | 4.30e-04 | 148 | 19 | 3 | SM00228 | |
| Domain | - | 4.48e-04 | 150 | 19 | 3 | 2.30.42.10 | |
| Domain | PDZ | 4.56e-04 | 151 | 19 | 3 | PS50106 | |
| Domain | PDZ | 4.65e-04 | 152 | 19 | 3 | IPR001478 | |
| Domain | PHD | 2.60e-03 | 75 | 19 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 2.88e-03 | 79 | 19 | 2 | IPR019787 | |
| Domain | PHD | 3.64e-03 | 89 | 19 | 2 | SM00249 | |
| Domain | Znf_PHD | 3.80e-03 | 91 | 19 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 4.14e-03 | 95 | 19 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 4.22e-03 | 96 | 19 | 2 | PS01359 | |
| Domain | Znf_FYVE_PHD | 9.64e-03 | 147 | 19 | 2 | IPR011011 | |
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 15007166 | ||
| Pubmed | 2.83e-07 | 2 | 19 | 2 | 20833135 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 21940993 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 17185750 | ||
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 5.93e-06 | 7 | 19 | 2 | 23415230 | |
| Pubmed | Interaction between nucleosome assembly protein 1-like family members. | 1.86e-05 | 12 | 19 | 2 | 21333655 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 5.89e-05 | 807 | 19 | 5 | 30575818 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 8.01e-05 | 861 | 19 | 5 | 36931259 | |
| Pubmed | 1.39e-04 | 32 | 19 | 2 | 20301301 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.50e-04 | 256 | 19 | 3 | 33397691 | |
| Pubmed | 3.62e-04 | 259 | 19 | 3 | 31162944 | ||
| Interaction | LYN interactions | 2.50e-06 | 720 | 19 | 7 | int:LYN | |
| GeneFamily | PDZ domain containing | 2.46e-04 | 152 | 15 | 3 | 1220 | |
| GeneFamily | Tudor domain containing | 4.21e-04 | 37 | 15 | 2 | 780 | |
| GeneFamily | PHD finger proteins | 2.47e-03 | 90 | 15 | 2 | 88 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 9.61e-03 | 181 | 15 | 2 | 694 | |
| Coexpression | GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP | 1.11e-04 | 131 | 19 | 3 | M8933 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 1.17e-04 | 704 | 19 | 5 | M45672 | |
| Coexpression | GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP | 2.58e-04 | 174 | 19 | 3 | M2954 | |
| Coexpression | GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN | 2.71e-04 | 177 | 19 | 3 | M7632 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN | 2.89e-04 | 181 | 19 | 3 | M8889 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 3.49e-04 | 193 | 19 | 3 | M39321 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | 3.63e-04 | 486 | 19 | 4 | M18517 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP | 3.82e-04 | 199 | 19 | 3 | M9414 | |
| Coexpression | GSE17721_0.5H_VS_12H_CPG_BMDC_DN | 3.82e-04 | 199 | 19 | 3 | M4122 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 3.82e-04 | 199 | 19 | 3 | M6932 | |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_3_DN | 3.82e-04 | 40 | 19 | 2 | M2169 | |
| Coexpression | GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP | 3.88e-04 | 200 | 19 | 3 | M7282 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 3.88e-04 | 200 | 19 | 3 | M8087 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN | 3.88e-04 | 200 | 19 | 3 | M4062 | |
| Coexpression | GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP | 3.88e-04 | 200 | 19 | 3 | M9845 | |
| Coexpression | GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN | 3.88e-04 | 200 | 19 | 3 | M9692 | |
| Coexpression | GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN | 3.88e-04 | 200 | 19 | 3 | M6938 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN | 3.88e-04 | 200 | 19 | 3 | M6956 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | 4.16e-04 | 504 | 19 | 4 | M2157 | |
| Coexpression | MATSUDA_NATURAL_KILLER_DIFFERENTIATION | 4.68e-04 | 520 | 19 | 4 | MM1008 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#2_top-relative-expression-ranked_500 | 1.63e-07 | 56 | 19 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.10e-06 | 148 | 19 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k2 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-1 | 8.80e-06 | 332 | 19 | 5 | GSM538230_500 | |
| CoexpressionAtlas | B cells, B1b.PC, IgD+ IgM+ CD19+ CD43+ CD5- CD45R+, Peritoneal Cavity, avg-2 | 9.47e-06 | 337 | 19 | 5 | GSM538228_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.71e-05 | 218 | 19 | 4 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | 4.15e-05 | 774 | 19 | 6 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.17e-04 | 108 | 19 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k4 | |
| CoexpressionAtlas | B cells, B1a.PC, IgD+ IgM+ CD19+ CD43+ CD5+ CD45R+, Peritoneal Cavity, avg-3 | 1.74e-04 | 325 | 19 | 4 | GSM538222_500 | |
| CoexpressionAtlas | NK cells, NK.DAP10-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | 2.16e-04 | 344 | 19 | 4 | GSM538294_500 | |
| CoexpressionAtlas | NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3 | 2.77e-04 | 367 | 19 | 4 | GSM538309_500 | |
| CoexpressionAtlas | NK cells, NK.H+.MCMV1.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3 | 2.86e-04 | 370 | 19 | 4 | GSM538300_500 | |
| CoexpressionAtlas | NK cells, NK.49CI-.Sp, NK1.1+ CD3- Ly49C/I-, Spleen, avg-3 | 2.92e-04 | 372 | 19 | 4 | GSM538288_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_500 | 2.95e-04 | 373 | 19 | 4 | gudmap_developingLowerUrinaryTract_adult_ureter_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.02e-04 | 149 | 19 | 3 | gudmap_developingLowerUrinaryTract_adult_ureter_1000_k1 | |
| CoexpressionAtlas | NK cells, NK.49CI+.Sp, NK1.1+ CD3- Ly49C/I+, Spleen, avg-3 | 3.32e-04 | 385 | 19 | 4 | GSM538285_500 | |
| CoexpressionAtlas | NK cells, NK.b2m-.Sp, NK1.1+ TCRb-, Spleen, avg-3 | 3.49e-04 | 390 | 19 | 4 | GSM538291_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.79e-04 | 161 | 19 | 3 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_ureter_emap-29479_top-relative-expression-ranked_1000 | 3.83e-04 | 736 | 19 | 5 | gudmap_developingLowerUrinaryTract_adult_ureter_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_200 | 3.86e-04 | 162 | 19 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200 | |
| CoexpressionAtlas | NK cells, NK.DAP12-.Sp, NK1.1+ CD3-, Spleen, avg-3 | 3.92e-04 | 402 | 19 | 4 | GSM538297_500 | |
| CoexpressionAtlas | NK cells, NK.49H+.Sp, NK1.1+ Ly49H+, Spleen, avg-3 | 3.95e-04 | 403 | 19 | 4 | GSM605814_500 | |
| CoexpressionAtlas | NK cells, NK.Sp, NK1.1+, Spleen, avg-3 | 4.18e-04 | 409 | 19 | 4 | GSM538315_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#2_top-relative-expression-ranked_200 | 4.18e-04 | 34 | 19 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_200_k2 | |
| CoexpressionAtlas | NK cells, NK.MCMV7.Sp, CD3-,NK1.1+, Spleen, avg-3 | 4.26e-04 | 411 | 19 | 4 | GSM538312_500 | |
| CoexpressionAtlas | NK cells, NK.H+.MCMV7.Sp, NK1.1+ TCRb- Ly49H+, Spleen, avg-3 | 4.34e-04 | 413 | 19 | 4 | GSM538303_500 | |
| CoexpressionAtlas | NK cells, NK.49H-.Sp, NK1.1+, Spleen, avg-3 | 4.34e-04 | 413 | 19 | 4 | GSM605817_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#1_top-relative-expression-ranked_500 | 5.51e-04 | 39 | 19 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k1 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#4_top-relative-expression-ranked_500 | 5.80e-04 | 40 | 19 | 2 | gudmap_kidney_adult_Mesangium_Meis_k4_500 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | 8.30e-04 | 872 | 19 | 5 | gudmap_kidney_adult_Mesangium_Meis_1000 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.64e-07 | 172 | 19 | 4 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.31e-06 | 197 | 19 | 4 | 7870c0651caefb0ed13d9f9dab43b5f24d6a9efc | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.11e-05 | 128 | 19 | 3 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-05 | 155 | 19 | 3 | b5d5c38b269e9318970fcce564df1c8ed7a7ccc6 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.83e-05 | 169 | 19 | 3 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-05 | 170 | 19 | 3 | 545c755b057871b7a22221a049a63a61713dad1d | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 171 | 19 | 3 | 06fe7eeffc6e0735342b88e1d1ae26a9b477fece | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-05 | 176 | 19 | 3 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-05 | 176 | 19 | 3 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 5.63e-05 | 178 | 19 | 3 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 178 | 19 | 3 | 408e41c853f608965cef9111fb87fdc311cdc7a8 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.63e-05 | 178 | 19 | 3 | 291ffc52b824e4f59078147eb640ef34e24fb450 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 180 | 19 | 3 | 54e3f289a37d4cfbfca4fb284c3b52e9c7d9da97 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 5.82e-05 | 180 | 19 | 3 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 180 | 19 | 3 | bfc8568d57034dd9c9e07edae94479a48ca0706d | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 5.92e-05 | 181 | 19 | 3 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.52e-05 | 187 | 19 | 3 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.73e-05 | 189 | 19 | 3 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 6.83e-05 | 190 | 19 | 3 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 6.83e-05 | 190 | 19 | 3 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.83e-05 | 190 | 19 | 3 | ff774faf3f12759d11e50ed7d189288bb79e22e1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.94e-05 | 191 | 19 | 3 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | (2)_Fibroblasts-(21)_Fibro-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.94e-05 | 191 | 19 | 3 | 5ee353c79055c08e8a3e2b43a0345bceb09f3890 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.16e-05 | 193 | 19 | 3 | 35998200890fef12e7f4a3dc65eca1c30d19fa93 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 7.16e-05 | 193 | 19 | 3 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-05 | 194 | 19 | 3 | b191851b2287afc8c47320f5488fd22e2a454aa6 | |
| ToppCell | Healthy-B_intermediate|Healthy / disease group, cell group and cell class | 7.27e-05 | 194 | 19 | 3 | aabee48bf689367edae2079b4b90d253715f1097 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 7.38e-05 | 195 | 19 | 3 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.38e-05 | 195 | 19 | 3 | a2fe352682f548001ca2ee056e7a54af10134453 | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 7.38e-05 | 195 | 19 | 3 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | Healthy-B_intermediate|World / disease group, cell group and cell class | 7.38e-05 | 195 | 19 | 3 | 9de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CTL|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.49e-05 | 196 | 19 | 3 | ad9b0651cb2a15b750e453b2dcf782bca08b4fe7 | |
| ToppCell | Int-URO-Myeloid-CD14_Mono|Int-URO / Disease, Lineage and Cell Type | 7.49e-05 | 196 | 19 | 3 | e6a897c29404119fb40c29033d0198a866015bf8 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.49e-05 | 196 | 19 | 3 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | (5)_Epi_stratified|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.61e-05 | 197 | 19 | 3 | 2b35bcff0637cd5af9bec1ac6bca2b59a92e2f64 | |
| ToppCell | URO-Myeloid-CD14_Mono|URO / Disease, Lineage and Cell Type | 7.61e-05 | 197 | 19 | 3 | 45c16125fa32e50304fdd45a7cb457488bd50ee3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-05 | 197 | 19 | 3 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | Bac-SEP-Myeloid-CD14_Mono|Bac-SEP / Disease, Lineage and Cell Type | 7.61e-05 | 197 | 19 | 3 | d9f1d87ea08139399351db154b63994aa1c9b052 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.61e-05 | 197 | 19 | 3 | e5a1e846bbfec234cb50c87c1f24beb43fce6856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.61e-05 | 197 | 19 | 3 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.61e-05 | 197 | 19 | 3 | 5a81796c813bab9f8b7aedfd5e3a6a58c257837b | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.72e-05 | 198 | 19 | 3 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.72e-05 | 198 | 19 | 3 | 100091c91fde604daf110f20b44505f240f93ae8 | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.72e-05 | 198 | 19 | 3 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_stratified|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 7.72e-05 | 198 | 19 | 3 | b3aec042912ce53bd86e86b6761a0604d9998ab5 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.72e-05 | 198 | 19 | 3 | eae8c29d68cc94bfbd15e487ad855639c2a4fcc9 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.72e-05 | 198 | 19 | 3 | 2f94fb4a1719d5adddb4fd3dfaf099ee2b642011 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-promonocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.72e-05 | 198 | 19 | 3 | a11de3836fc1575bec5f6c701836fe2fb5a1027a | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.72e-05 | 198 | 19 | 3 | 73e9ada6998c09ae3a3a66e920b28694b7f9cf6b | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.72e-05 | 198 | 19 | 3 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 199 | 19 | 3 | 87956fcb39c2e3e99622ff05f99267d7621a78fc | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 7.84e-05 | 199 | 19 | 3 | ea1e2ccde3930fab6d04a9bf130837455c742474 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.84e-05 | 199 | 19 | 3 | 7f5d47e49776114d9f4a42017fead9eeb415a94c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 199 | 19 | 3 | c6da5c517dbcfa621fa6dda9e0c1985ba2f3bbdb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 199 | 19 | 3 | b9613e88c4b752529d6ae20857744418207b0830 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.84e-05 | 199 | 19 | 3 | aa30a57c0907d012942e7babdbff6ea4d01d7798 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.84e-05 | 199 | 19 | 3 | 5caaf66b6cddcc8f0d0aee3c9ba80d02075e87e5 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.84e-05 | 199 | 19 | 3 | 7e5a56bb2ac441a8fa4ad0b928f9c0c82d128190 | |
| ToppCell | Sepsis-Int-URO-Myeloid-CD14+_Monocyte|Int-URO / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | 7471a202c36800f488a738c6803d9fb3fe167aad | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.96e-05 | 200 | 19 | 3 | 8f585920bf7ad8bb489c78e2db42435962de4416 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-CD14+_Monocyte|Bac-SEP / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | 1958c32c728a250e08c6313c40e3582dcff564c3 | |
| ToppCell | Sepsis-URO-Myeloid-CD14+_Monocyte|URO / Disease, condition lineage and cell class | 7.96e-05 | 200 | 19 | 3 | 209976dbbfc1edbeb3ea128cd0453ec9572f54cb | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.96e-05 | 200 | 19 | 3 | f65837b51bce94c08125b1a2e1a696a15267f64b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic-monocyte-CD14_monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.96e-05 | 200 | 19 | 3 | 07197f95282ee607db17b92fea1376051e65fc50 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.96e-05 | 200 | 19 | 3 | 527b7388700096686293f3f6b112269e87908dfa | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 9.40e-05 | 34 | 19 | 2 | 3ff1ad679da59252f0e3caec27f25d3f30984d7f | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-04 | 55 | 19 | 2 | 7916216b3a24f9c6b966aa5392fc2bc43b3d2c4c | |
| ToppCell | mild-immature_Neutrophil|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.63e-04 | 83 | 19 | 2 | f7225bc24ad6df3a41375cc4614af824e0db3559 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.99e-04 | 105 | 19 | 2 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| ToppCell | COVID-19-APC-like-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations) | 1.29e-03 | 126 | 19 | 2 | 9f94291b1db020cc0ebf9c8de4e01bd883295672 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-RGCs_3|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.50e-03 | 136 | 19 | 2 | 5e209185b5f6e9347829fc9066f0b2c3711df057 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-03 | 137 | 19 | 2 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-03 | 138 | 19 | 2 | 611fe0fb284e12678f9c47a0bdbfc367a93c52b3 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-03 | 139 | 19 | 2 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | Lymphoid-T_cells_(Cd8+_T_cell)|World / shred on cell class and cell subclass (v4) | 1.57e-03 | 139 | 19 | 2 | c85f50fb536f4df6fa4dbdebe48e1ecea1df1121 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-03 | 142 | 19 | 2 | 5ef69032ed7dc5f2244b84e8c6662290bf59a34b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.63e-03 | 142 | 19 | 2 | f720f13b339589fa924a42e89393e5db0b26300b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.66e-03 | 143 | 19 | 2 | 5a279da1cd8e63db32f7c85a73b493c2121d0a96 | |
| ToppCell | E15.5-Hematopoietic-Erythroid-enucleate_erythrocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-03 | 143 | 19 | 2 | e4207ff9e8248813356631631bbf31a63f23ad3c | |
| ToppCell | E15.5-Hematopoietic-Erythroid|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-03 | 143 | 19 | 2 | 15a7b93c381ef0f455f99f3abf4b2b9454d35bc4 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-03 | 145 | 19 | 2 | 997bd540c43725a85ca97e4b79ebe0d336860287 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-03 | 148 | 19 | 2 | 438fe292d29be0206e1d9fd59ede5f8368f13665 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-03 | 149 | 19 | 2 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.80e-03 | 149 | 19 | 2 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-03 | 150 | 19 | 2 | 207fc230d7721149c7afc7970dd56817f52801d8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-03 | 151 | 19 | 2 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-03 | 151 | 19 | 2 | b545823113a3450c5f841f7de48bf0937593544f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-03 | 151 | 19 | 2 | 0cc2f4aec3dae4603fa831f22c40f897e68b34e2 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.87e-03 | 152 | 19 | 2 | b2e29fbda6b5f2d87cfc05423caf9cbf3b04ac65 | |
| ToppCell | Hippocampus-Macroglia-CSF_related|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.87e-03 | 152 | 19 | 2 | c2b6cc41546cbd46b9ea5d28a7c66f6330a27df2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.89e-03 | 153 | 19 | 2 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-03 | 153 | 19 | 2 | a8f83ec640fae51d4fba34b92e3d6cca4999e930 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-03 | 154 | 19 | 2 | d0a1ff02a7e91f6923aa85b65094f78e357e377d | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.94e-03 | 155 | 19 | 2 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.97e-03 | 156 | 19 | 2 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | facs-Brain_Myeloid-Cerebellum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-03 | 156 | 19 | 2 | 28c4fb4d2c6c47696c3a6722998f9da5a8923323 | |
| ToppCell | facs-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 157 | 19 | 2 | a84377028c661f8f3ecae0f6082abdd859faf0c8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-03 | 159 | 19 | 2 | 03d77e7fee40262bf0942aab96b273f1c4f5d8e3 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-03 | 159 | 19 | 2 | 5c7a099aa84ecc62bf9b5e1609e5b6b77889f175 | |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.83e-05 | 195 | 19 | 4 | 4771_UP | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; PC3; HT_HG-U133A | 1.90e-05 | 197 | 19 | 4 | 5090_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.94e-05 | 198 | 19 | 4 | 1482_DN | |
| Disease | Primary ciliary dyskinesia | 2.44e-04 | 36 | 19 | 2 | cv:C0008780 | |
| Disease | bone quantitative ultrasound measurement | 2.87e-04 | 39 | 19 | 2 | EFO_0004514 | |
| Disease | Malignant neoplasm of breast | 4.80e-04 | 1074 | 19 | 5 | C0006142 | |
| Disease | Colorectal Carcinoma | 9.26e-04 | 702 | 19 | 4 | C0009402 | |
| Disease | urate measurement | 2.26e-03 | 895 | 19 | 4 | EFO_0004531 | |
| Disease | Mammary Neoplasms, Human | 4.39e-03 | 525 | 19 | 3 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 4.39e-03 | 525 | 19 | 3 | C4704874 | |
| Disease | Mammary Neoplasms | 4.44e-03 | 527 | 19 | 3 | C1458155 | |
| Disease | Breast Carcinoma | 4.70e-03 | 538 | 19 | 3 | C0678222 | |
| Disease | heel bone mineral density, urate measurement | 6.04e-03 | 182 | 19 | 2 | EFO_0004531, EFO_0009270 | |
| Disease | C-reactive protein measurement | 6.58e-03 | 1206 | 19 | 4 | EFO_0004458 | |
| Disease | hair colour measurement | 6.81e-03 | 615 | 19 | 3 | EFO_0007822 | |
| Disease | biological sex | 9.48e-03 | 230 | 19 | 2 | PATO_0000047 | |
| Disease | lymphocyte:monocyte ratio | 1.46e-02 | 288 | 19 | 2 | EFO_0600088 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKPMFSKQTIEFKKM | 216 | Q7Z4H9 | |
| GKGKKSKFKMPKIHM | 5016 | Q09666 | |
| KSPKTKKTMFGKMYF | 5076 | Q09666 | |
| SSMKFYRGVKKKMKP | 1486 | Q8WZ64 | |
| FFMESMSFKKKPKTE | 261 | Q8WWL7 | |
| DYKTMFMSGKEIKKK | 326 | Q9Y483 | |
| KRAKMDKSMFVKIKT | 696 | O95835 | |
| PEGKKKGKFKTMKML | 831 | Q8N3F8 | |
| MIFDPTMSKKKKKKK | 6 | P20042 | |
| PFCGTISSKKKKKMM | 296 | Q9NZW5 | |
| FKTMHKCVKQFKDMP | 1061 | Q9P2D7 | |
| YKSSFKEAKMMIRPK | 421 | Q14314 | |
| DRKTVKMMYQKKKFA | 191 | P30740 | |
| MAFLMKKKKFKFQTT | 1 | Q5T9C2 | |
| MMKKKKFKFKVDFEL | 1 | Q5T8I3 | |
| KKNKEMKFAVKFMFS | 286 | Q5T4F7 | |
| VTAKDSKFKMPKFKM | 826 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 991 | Q8IVF2 | |
| VTAKDSRFKMPKFKM | 1156 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 1321 | Q8IVF2 | |
| LTTKDSKFKMPKFKM | 1486 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 1651 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 1816 | Q8IVF2 | |
| MTAKDSKFKMPKFKM | 1981 | Q8IVF2 | |
| LTTKDSKFKMPKFKM | 2146 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 2311 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 2641 | Q8IVF2 | |
| MTAKDSKFKMPKFKM | 2806 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 2971 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 3136 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 3301 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 3466 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 3631 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 3796 | Q8IVF2 | |
| MTAKDSKFKMPKFKM | 3961 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 4126 | Q8IVF2 | |
| MTAKDSKFKMPKFKM | 4291 | Q8IVF2 | |
| VTAKDSKFKMPKFKM | 4456 | Q8IVF2 | |
| LKMSKKKAKMPSAST | 406 | Q96PU4 | |
| DAFFPDFKKMKSMKL | 301 | Q8N427 | |
| MKAYAFHQKKESMKK | 191 | Q9H788 | |
| LKKTPKKKMKMVTGA | 16 | Q9Y3B9 | |
| KKDAKSNYKMMFVKS | 166 | O00193 | |
| KPMSEMKFHKKVGKL | 641 | Q9Y6X0 |